Harmful And Dangerous Incretin Mimetic Drugs For Type 2 Diabetes Increase The Risk Of Pancreatitis And Pre-Cancerous Findings Of The Pancreas

type2According to American Diabetes Association 25.8 million children and adults in the United States, that makes up 8.3% of population, have diabetes. Type 2 Diabetes Mellitus is a lifelong disease that affects the way your body uses food for energy. This means that the pancreas cannot make enough insulin resulting in high blood sugar levels.

incretinDrugs that are used to treat type 2 diabetes belong to the incretin mimetics class. Incretin is a natural hormone which makes your body release insulin after eating, insulin lowers your blood sugar. Incretin mimetics “mimic” the activities of the incretin hormone by:

  • encouraging your body to release insulin when your blood sugar level rises
  • preventing the pancreas from producing to much glucagon
  • slowing down the rate at which your stomach empties after eating

Continue reading

Liraglutide or Victoza – How This Harmful Drug Affects People with Type 2 Diabetes

A drug may be helpful or harmful. Learning the facts about drugs can help you see the risks of chasing this excitement or escape. Here’s what you need to know about Liraglutide (Victoza). Liraglutide is a long acting glucagon-like peptide-1 agonist logo_victoza_600x252medication. The drug has been marketed as Victoza and it belongs to the group of incretin mimetics. Liraglutide in its Victoza form is administered as a subcutaneous injection of the abdomen, thigh or arm and it is used to treat people who have type 2 diabetes and who are not able to control their blood sugar levels with oral medicines. This drug is manufactured by Novo Nordisk.

Continue reading

Why Is Exenatide (Byetta) Harmful For People Treating Type 2 Diabetes

type 2According to diabetes.org  25.8 million children and adults in the United States—8.3% of the population—have diabetes.  Type 2 Diabetes is a lifelong disease that affects the way your body uses food for energy. This disease develops when the cells of the body become resistant to insulin and/or when the pancreas cannot make enough insulin resulting in high blood sugar levels.

type 2 1Exenatide, also known as Byetta and Bydureon, is a drug meant to treat type 2 diabetes and is administered as a subcutaneous injection given twice daily any time within the 60 minutes before the first and last meal of the day. It belongs to the group of incretin mimetics that means that the drug acts like the natural hormone incretin by:

  • encouraging the body to release insulin when your blood sugar level rises
  • preventing your pancreas from producing too much glucagon
  • slowing down the rate at which your stomach empties after eating

Continue reading